HSCS
Income statement / Annual
Last year (2025), HeartSciences Inc.'s total revenue was $4.35 K,
a decrease of 76.61% from the previous year.
In 2025, HeartSciences Inc.'s net income was -$8.77 M.
See HeartSciences Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
04/30/2025 |
04/30/2024 |
04/30/2023 |
04/30/2022 |
04/30/2021 |
04/30/2020 |
| Operating Revenue |
$4.35 K |
$18.60 K |
$5.15 K |
$14.37 K |
$25.60 K |
$64.18 K |
| Cost of Revenue |
$1.88 K
|
$6.08 K
|
$2.80 K
|
$7.89 K
|
$10.67 K
|
$46.46 K
|
| Gross Profit |
$2.47 K
|
$12.52 K
|
$2.35 K
|
$6.48 K
|
$14.94 K
|
$17.72 K
|
| Gross Profit Ratio |
0.57
|
0.67
|
0.46
|
0.45
|
0.58
|
0.28
|
| Research and Development Expenses |
$4.39 M
|
$2.88 M
|
$2.46 M
|
$3.00 M
|
$1.71 M
|
$2.04 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$3.97 M
|
$3.44 M
|
$3.65 M
|
$1.71 M
|
$874.62 K
|
$1.80 M
|
| Other Expenses |
$0.00
|
$0.00
|
$1.85 K
|
$2.56 K
|
-$3.45 K
|
$19.89 K
|
| Operating Expenses |
$8.36 M
|
$6.32 M
|
$6.12 M
|
$4.72 M
|
$2.58 M
|
$3.84 M
|
| Cost And Expenses |
$8.36 M
|
$6.32 M
|
$6.12 M
|
$4.72 M
|
$2.59 M
|
$3.88 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$500.45 K
|
$354.08 K
|
$243.17 K
|
$371.62 K
|
$132.45 K
|
$2.81 K
|
| Depreciation & Amortization |
$127.96 K
|
$95.13 K
|
$26.92 K
|
$26.57 K
|
$33.61 K
|
$63.83 K
|
| EBITDA |
-$8.14 M |
-$6.16 M |
-$6.08 M |
-$4.43 M |
-$2.29 M |
-$3.74 M |
| EBITDA Ratio |
-1870.53
|
-330.97
|
-1181.4
|
-308.22
|
-89.29
|
-58.34
|
| Operating Income Ratio |
-1920.13
|
-339.02
|
-1186.98
|
-327.66
|
-100.3
|
-59.49
|
| Total Other Income/Expenses Net |
-$412.66 K
|
-$299.44 K
|
-$241.33 K
|
-$118.86 K
|
$115.96 K
|
$7.07 K
|
| Income Before Tax |
-$8.77 M
|
-$6.61 M
|
-$6.35 M
|
-$4.83 M
|
-$2.45 M
|
-$3.81 M
|
| Income Before Tax Ratio |
-2015
|
-355.12
|
-1233.84
|
-335.93
|
-95.77
|
-59.38
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$8.77 M
|
-$6.61 M
|
-$490.85 M
|
-$4.58 M
|
-$2.58 M
|
-$3.83 M
|
| Net Income Ratio |
-2015
|
-355.12
|
-95311.51
|
-318.52
|
-100.81
|
-59.73
|
| EPS |
-9.34 |
-18.74 |
-6173.88 |
-137.94 |
-77.89 |
-115.69 |
| EPS Diluted |
-9.34 |
-18.74 |
-6173.88 |
-137.94 |
-77.89 |
-115.69 |
| Weighted Average Shares Out |
$938.26 K
|
$352.52 K
|
$79.51 K
|
$33.19 K
|
$33.14 K
|
$33.14 K
|
| Weighted Average Shares Out Diluted |
$938.26 K
|
$352.52 K
|
$79.51 K
|
$33.19 K
|
$33.14 K
|
$33.14 K
|
| Link |
|
|
|
|
|
|
